XYZAL

This brand name is authorized in Austria, Cyprus, Estonia, Finland, Hong Kong, Croatia, Ireland, Italy, Japan, Lithuania, Malta, Netherlands, Poland, Romania, Singapore, United Kingdom, United States, South Africa

Active ingredients

The drug XYZAL contains one active pharmaceutical ingredient (API):

1 Levocetirizine UNII SOD6A38AGA - LEVOCETIRIZINE DIHYDROCHLORIDE

Levocetirizine, the ® enantiomer of cetirizine, is a potent and selective antagonist of peripheral H1-receptors. Pharmacodynamic studies in healthy volunteers demonstrate that, at half the dose, levocetirizine has comparable activity to cetirizine, both in the skin and in the nose. Read about Levocetirizine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
XYZAL Oral solution	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R06AE09	Levocetirizine	R Respiratory system → R06 Antihistamines for systemic use → R06A Antihistamines for systemic use → R06AE Piperazine derivatives
Discover more medicines within R06AE09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1138126, 1138137, 1148521, 1148532, 1148543, 1148554, 1148565, 1148587, 1148598, 1148600, 1148611, 1148622, 1148633, 1148644, 1148655, 1148666, 1148677, 1148688, 1223064
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 007908, 008641, 059406, 150194, 165240
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 117602, 36036
Country: HK	Department of Health Drug Office	Identifier(s): 49629, 54600
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-232981652
Country: IE	Health Products Regulatory Authority	Identifier(s): 53968, 53974, 74700, 74725, 74732, 74770
Country: IT	Agenzia del Farmaco	Identifier(s): 035666080
Country: JP	医薬品医療機器総合機構	Identifier(s): 4490028F1027, 4490028Q1028
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1019998, 1019999, 1020000, 1020001, 1020002, 1020005, 1020006, 1020007, 1020008, 1020009, 1020010, 1020011, 1020012, 1020013, 1020014, 1020015, 1020016, 1021389, 1022346, 1069326, 1082388
Country: MT	Medicines Authority	Identifier(s): MA030/00701, MA030/00702
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 60976, 81698
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100147912, 100163510, 100399068, 100407336
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W58148001, W58148002, W58148003, W65372001, W65372002, W65372003, W65372005, W65372006, W65372007, W65372008, W65372009, W65372010, W65372011, W65372012, W65372013, W65372014, W65372015, W65372016, W65372017
Country: SG	Health Sciences Authority	Identifier(s): 12084P, 13469P, 13470P
Country: US	FDA, National Drug Code	Identifier(s): 0024-5803, 0024-5804
Country: ZA	Health Products Regulatory Authority	Identifier(s): 36/5.7.1/0425, 41/5.7.1/0032